PharmaMar is a global commercial stage biopharmaceutical company focused on oncology and committed to research and development which takes inspiration from the sea to discover molecules with novel mechanisms of action with antitumor activity. We are a fully integrated company from discovery to commercialization that seeks innovative products to provide healthcare professionals and patients with new tools to treat cancer. With subsidiaries in Europe and the United States, and strong corporate partners such as Janssen, Chugai and Taiho, PharmaMar has an important late stage pipeline of drug candidates as well as a robust R&D oncology program.